Stay updated on t-PA Prophylaxis Clinical Trial
Sign up to get notified when there's something new on the t-PA Prophylaxis Clinical Trial page.

Latest updates to the t-PA Prophylaxis Clinical Trial page
- Check2 days agoChange DetectedThe web page has undergone significant content changes, including the removal of detailed descriptions of a pilot study on the effectiveness of tissue plasminogen activator (t-PA) in reducing catheter-associated infections and thrombosis, and the addition of a new version revision. The study's location and the centralized pharmacy's role in preparing the study drug have also been highlighted.SummaryDifference38%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check59 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check73 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
Stay in the know with updates to t-PA Prophylaxis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the t-PA Prophylaxis Clinical Trial page.